CW
LTRN icon

Curio Wealth’s Lantern Pharma LTRN Stock Holding History

Curio Wealth’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$2.74K – 687
2026
Q1 		$2.74K Hold
2,000
– – ﹤0.01% 298
2025
Q4 		$6.68K Buy
+2,000
New +$7.45K ﹤0.01% 278
2025
Q3 		– Sell
-2,000
Closed -$6.32K – 329
2025
Q2 		$6.32K Buy
2,000
+1,999
+199,900% +$6.75K ﹤0.01% 226
2025
Q1 		$6.38K Sell
1
-1,999
-100% -$8.29K ﹤0.01% 257
2024
Q4 		$6.38K Buy
+2,000
New +$6.85K ﹤0.01% 235

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Quadrature Capital
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Curio Wealth's LTRN Position: Q2 2026 in Review

Curio Wealth sold out of Lantern Pharma (LTRN) in Q2 2026, closing a stake of 2,000 shares — an estimated $2.74K sold.

Curio Wealth first reported a position in LTRN in Q4 2024 and held it in 5 quarters. The position peaked at $6.68K in Q4 2025. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Curio Wealth reported no remaining Lantern Pharma position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 2,000 Lantern Pharma shares in Q2 2026, an estimated $2.74K.
  • Curio Wealth first reported a position in Lantern Pharma in Q4 2024 and held it in 5 quarters.
  • Curio Wealth's Lantern Pharma position peaked at $6.68K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.